More Data Back Guillain-Barr é Risk With Janssen COVID Shot More Data Back Guillain-Barr é Risk With Janssen COVID Shot

Observed cases of Guillain-Barr é syndrome after receipt of the Janssen shot were two to three times greater than background rates within 3-6 weeks of vaccination, new US surveillance data show.Medscape Medical News
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Neurology & Neurosurgery News Source Type: news